OBI Pharma (ROCO:4174) Change In Inventory: NT$9.77 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4174 OBI Pharma Inc ROCO:4174
36 GF Score
Price NT$26.15
! 8 Warning Signs
View Full Analysis

What is OBI Pharma Change In Inventory?

OBI Pharma ROCO:4174 -0.95% 36 Change In Inventory is NT$9.77 Mil as of Jun. 2026. GuruFocus rates ROCO:4174 with a GF Score™ of 36/100. The stock has 8 warning signs investors should review.

OBI Pharma's change in inventory for the quarter that ended in Jun. 2026 was NT$1.68 Mil. It means OBI Pharma's inventory declined by NT$1.68 Mil from Mar. 2026 to Jun. 2026 .

OBI Pharma's change in inventory for the fiscal year that ended in Dec. 2025 was NT$9.30 Mil. It means OBI Pharma's inventory declined by NT$9.30 Mil from Dec. 2024 to Dec. 2025 .

OBI Pharma's Total Inventories for the quarter that ended in Jun. 2026 was NT$18.05 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. OBI Pharma's Days Inventory for the quarter that ended in Jun. 2026 was 59.10.

Inventory Turnover measures how fast the company turns over its inventory within a year. OBI Pharma's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.54.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. OBI Pharma's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 1.24.

OBI Pharma  (ROCO:4174) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OBI Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=18.883/29.156*365 / 4
=59.10

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

OBI Pharma's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=29.156 / 18.883
=1.54

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OBI Pharma's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=18.883 / 15.28
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OBI Pharma Change In Inventory Related Terms

OBI Pharma Change In Inventory Historical Data

* Premium members only.

The historical data trend for OBI Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OBI Pharma Change In Inventory Chart

OBI Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.20 -9.74 -3.96 -1.79 9.30

OBI Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 1.74 7.64 -1.29 1.68
ROCO:4174
36GF Score
OBI Pharma Inc ROCO:4174
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OBI Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$9.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$9.77 Mil mean?
OBI Pharma (ROCO:4174) has a Change In Inventory of NT$9.77 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for OBI Pharma and its competitors.
Is OBI Pharma's Change In Inventory too high?
OBI Pharma's current Change In Inventory is NT$9.77 Mil. Overall, OBI Pharma has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does OBI Pharma's Change In Inventory compare to VRTX and REGN?
OBI Pharma's Change In Inventory of NT$9.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for OBI Pharma and its competitors. OBI Pharma's current Change In Inventory is NT$9.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OBI Pharma stock overvalued right now?
OBI Pharma (ROCO:4174) has a current Change In Inventory of NT$9.77 Mil. The current Change In Inventory is NT$9.77 Mil. OBI Pharma's overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For OBI Pharma (ROCO:4174), the current Change In Inventory is NT$9.77 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OBI Pharma Business Description

Address Zhongxiao East Road, 6th Floor, No. 508, Section 7, Nangang District, Taipei, TWN, 115
OBI Pharma Inc is engaged in the research and development of novel therapeutic agents and biologics for patients with unmet medical needs. The company has three reportable segments: the anti-cancer new drug segment, the botulinum toxin new drug segment, and the CDMO segment. Geographically, it generates the majority of its revenue from Taiwan.
36GF Score

Get the complete analysis for ROCO:4174

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.15
Price